Physical characteristics of solid state and dispersed ETFD lead SDN candidate (70 wt% LPV, 20 wt% PVA, 10 wt% TPGS. a) p-XRD of the ETFD monolith recorded directly following freeze drying (insert shows nonprocessed LPV powder). b) Dz, c) PDI and d)  monitoring of stored ETFD monoliths after redispersion; several ETFD monoliths were prepared and stored under ambient conditions. Individual samples were redispersed approximately each month (1 mg mL -1 in water) and the resulting nanodispersion was characterised by DLS. e) Dz, f) PDI and g)  monitoring of ETFD aqueous dispersions; ETFD monoliths were dispersed in water (1 mg mL -1 ) and monitored via DLS for 10 hours (stationary samples). h) Dz (filled circles) and  (open circles) of ETFD dispersions (1 mg mL -1 in water) at varied pH. In all cases, samples were studied at 25 o C and fixed error bars are shown derived from instrumental accuracy. (10% error). 
Supplementary Figure 7:
Comparative powder X-ray diffraction characterisation of the spray dried lead LPV SDN candidate (50 wt% LPV): A) after 14 months storage under ambient conditions, B) one day after manufacture, and C) LPV as received and prior to SDN manufacture.
Supplementary Figure 8:
Simulation of LPV pharmacokinetics through PBPK modelling. Mean plasma concentrations of LPV in a simulated cohort of 110 virtual individuals receiving 400/100 mg of LPV/RTV twice daily of the LPV aqueous solution (<0.1% DMSO), 10 wt% LPV SDN with the lowest permeability and 10 wt% LPV SDN with the highest permeability. , 25 o C. Where blank shows sample failed DLS criteria; 1) complete aqueous dispersion; 2) Dz <1000 nm; 3) Dz standard deviation between repeated measurement <10% (n = 3; Fig. 2C&D ) and; 4) PDI <0.5. 608 ± 4.9 516 ± 0.3 605 ± 1.9 688 ± 3.9 PVA / T-20 621 ± 2.4 656 ± 1.9 660 ± 2.1 778 ± 3.0 PVA / T-80 523 ± 3.2 637 ± 1.1 902 ± 0.3 HPMC / T-80 746 ± 1.4 518 ± 3.0 614 ± 10.4 739 ± 1.8 PVA / NDC 617 ± 5.9 595 ± 1.9 653 ± 2.9 HPMC / NDC 839 ± 6.4 891 ± 7.1 970 ± 6.1 1390 ± 6.3 HPMC / Solutol 485 ± 4.2 Measured using DLS, 1 mg mL
Supplementary

o C. Where blank shows sample unable to give DLS data PVA (25) TGPS ( Measured using DLS 1 mg mL -1 , 25 o C. Dash shows data not measured. 
